+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of Adverse Drug Reactions in CAD STEMI Patients Treated in the Cardiac Intensive Care Unit at the Public Hospital in Bandung, Indonesia



Prevalence of Adverse Drug Reactions in CAD STEMI Patients Treated in the Cardiac Intensive Care Unit at the Public Hospital in Bandung, Indonesia



Scientia Pharmaceutica 84(1): 167-179



Adverse drug reactions (ADRs) are associated with morbidity, mortality, and can contribute to increased healthcare costs. This study was conducted to identify the occurence, types, and management of ADRs, as well as analyze the causal relationship, severity, and preventability of ADRs. The study was observational analysis with concurrent data collection from patients with Coronary Artery Disease-ST segment Elevation Myocardial Infarction (CAD-STEMI) treated in the Cardiac Intensive Care Unit (CICU) at a hospital in Bandung Indonesia, during the period of December 2013 to March 2014. The occurence of identified ADRs was assessed using the probability scale of Naranjo, while the severity by the scale of Hartwig and their preventability was evaluated using the scale of Schumock-Thornton. 49 ADRs were identified in 29 patients. Organ systems most affected by the ADRs were the cardiovascular and body electrolyte, each accounting for 20.41%. The hematology and gastrointestinal systems each contributed 18.37% to ADR occurrences. The causal relationship was mostly classified as "probable," accounting for 69.39%. With regard to severity, most ADRs were classified as "moderate" at level 3, contributing to 53.06% of the occurence. In terms of preventability, most of the ADRs fell into the "non-preventable" category (79.59%). The most widely applied ADRs management was administration of an antidote or other treatments (40.82%). Further analysis revealed that the average number of drug types and duration of hospitalization significantly affected the presence of ADRs. Taken together, most patients with CAD STEMI treated in the CICU of the studied hospital experienced non-preventable ADRs and were treated with antidote or other treatments.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058615453

Download citation: RISBibTeXText

PMID: 27110507

DOI: 10.3797/scipharm.isp.2015.08


Related references

Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiology and Drug Safety 18(7): 639-645, 2009

Prevalence and Characteristics of Adverse Drug Reactions in Neurosurgical Intensive Care Patients. Yearbook of Critical Care Medicine 2007: 279-280, 2007

Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients. Neurosurgery 58(3): 426-33; Discussion 426-33, 2006

Survival and outcome prediction using the Apache III and the out-of-hospital cardiac arrest (OHCA) score in patients treated in the intensive care unit (ICU) following out-of-hospital, in-hospital or ICU cardiac arrest. Resuscitation 83(6): 728-733, 2012

Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil. Clinics 66(1): 9, 2011

Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital. Journal of Pharmacology and Pharmacotherapeutics 3(4): 308-313, 2012

Adverse drug reactions in the new born intensive care unit. Pediatric Researchpart 2: 422, 1978

Adverse drug reactions in a paediatric intensive care unit. Acta Paediatrica 84(4): 438-441, 1995

Adverse drug reactions in a paediatric intensive care unit. Farmacia Hospitalaria 36(5): 403-409, 2013

Genetic predisposition to adverse drug reactions in the intensive care unit. Critical Care Medicine 38(6 Suppl): S106-S116, 2010

Adverse drug reactions resulting in hyperthermia in the intensive care unit. Critical Care Medicine 38(6 Suppl): S244-S252, 2010

Incidence and costs of adverse drug reactions in a tertiary care pediatric intensive care unit. Journal of Clinical Pharmacology 53(5): 567-573, 2013

Admissions to a medical intensive care unit related to adverse drug reactions. American Journal of Health-System Pharmacy 64(17): 1840-1843, 2007

Computerized detection of adverse drug reactions in the medical intensive care unit. International Journal of Medical Informatics 80(8): 570-578, 2011

Characterization of adverse drug reactions causing admission to an intensive care unit. British Journal of Clinical Pharmacology 83(5): 1134-1140, 2017